Empagliflozin substantially decreased renal production of pro-inflammatory cytokines and chemokines (including tumor necrosis factor (TNF)), urine indicators of kidney inflammation (such as IL-6), and apoptosis in a diabetes-induced rat model [77]. This evidence concerns the gene IL6 and diabetes mellitus.